As our analysis revealed that mRNA and protein expression levels of SVIP were different in breast tumor tissues compared to control tissues, we examined the expression level of SVIP protein in commercially available breast cancer cell lines (Figure 5A). This evidence concerns the gene SVIP and breast neoplasm.